celecoxib and sesquiterpenes

celecoxib has been researched along with sesquiterpenes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ong, CN; Shen, HM; Shi, X; Won, YK1
Crooks, PA; Nakshatri, H; Neelakantan, S; Ralstin, M; Schmidt, CM; Sweeney, CJ; Vegeler, RC; Wu, H; Yip-Schneider, MT1
Crooks, PA; Holcomb, B; Neelakantan, S; Njoku, V; Ralstin, M; Schmidt, CM; Sweeney, CJ; Wu, H; Yip-Schneider, MT1
Edagawa, M; Goshima, H; Hirata, M; Inoue, M; Kawauchi, J; Kitajima, S; Maehara, Y; Murakami, A; Okamoto, T1

Other Studies

4 other study(ies) available for celecoxib and sesquiterpenes

ArticleYear
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
    Carcinogenesis, 2004, Volume: 25, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Celecoxib; Cell Death; Cyclooxygenase 2; Dinoprostone; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Cells; Female; Immunohistochemistry; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mice, Hairless; Mitogen-Activated Protein Kinases; Models, Chemical; Neoplasms, Radiation-Induced; p38 Mitogen-Activated Protein Kinases; Papilloma; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrazoles; Sesquiterpenes; Skin Neoplasms; Sulfonamides; Time Factors; Transcription Factor AP-1; Transcription, Genetic; Transcriptional Activation; Ultraviolet Rays

2004
Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
    The Journal of surgical research, 2007, Volume: 143, Issue:1

    Topics: Adenocarcinoma; Animals; Carcinogens; Celecoxib; Cricetinae; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lung; Lung Neoplasms; Mesocricetus; NF-kappa B; Nitrosamines; Pyrazoles; Random Allocation; Sesquiterpenes; Sulfonamides

2007
Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
    Pancreas, 2008, Volume: 37, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Proliferation; Chemokines, C; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Female; Ki-67 Antigen; Mesocricetus; Mucins; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Nitrosamines; Pancreatic Neoplasms; Pyrazoles; Sesquiterpenes; Sulfonamides; Time Factors

2008
Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through up-re
    The Journal of biological chemistry, 2014, Aug-01, Volume: 289, Issue:31

    Topics: Activating Transcription Factor 3; Apoptosis; Base Sequence; Celecoxib; Cell Line, Tumor; Colonic Neoplasms; DNA Primers; Endoplasmic Reticulum; Humans; Promoter Regions, Genetic; Pyrazoles; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Sulfonamides; TNF-Related Apoptosis-Inducing Ligand

2014